# 2026-08-11 POWER-HOUR decision

## Decision

**PAUSE / NO TRADE. Hold all five existing positions; do not add, trim, exit, or rotate before the close.**

Reason: no binding stop was breached; all holdings remained at or above the overlay's 10-point reduced-risk threshold; the only 13-point fresh candidates (RTX and CRWD) lacked required entry confirmation; the account was already at the five-position cap; only $6.21 was liquid; and CPI plus Iran/Hormuz/oil risk creates a material overnight gap hazard. No equity order was reviewed because no policy-compliant action survived the decision gate. No order was placed.

Scan time: started 2026-08-11 15:31:54 ET. Main live quote snapshot was 15:31-15:33 ET; XLK sector confirmation was 15:37 ET.

## Account and kill-switch verification

- Account used: **433711041 only**, nickname **Agentic**, cash individual account, active, self-directed, `agentic_allowed=true`, no leverage.
- Other accounts were observed only in the account-list prerequisite and were not queried for portfolio/positions/orders and were not traded.
- Portfolio: **$335.189817535** total; **$328.979817535** equities; **$6.21** cash; **$6.21** buying power; $0 options/futures/crypto/event contracts; $0 pending deposits.
- PDT: not restricted; 0 day trades in the current window.
- Open-order checks, queried independently: `new=0`, `queued=0`, `confirmed=0`, `unconfirmed=0`, `partially_filled=0`. Pending-order commitment: **$0.00**.
- Today's order/fill query: **0 orders, 0 fills**.
- 2026-08-10 verified portfolio snapshot: $337.250676883. Current drawdown from that recent verified snapshot: **-$2.060859348 / -0.611%**, far inside the -10% strategy kill switch.
- Mark-to-prior-close estimate from current holding quotes: approximately **-$2.42 / -0.717%**, inside the -3% daily-loss block. This is a calculated estimate, not a broker-supplied daily P&L field.
- No broker rejection, regulatory restriction, duplicated order, unresolved resting order, or strategy kill switch was found.

## Liquidity, deployment, and reserve

- Qualifying available liquid balance after pending orders: **$6.21**.
- 80% target if a setup qualified: **$4.968 (~$4.97)**.
- 20% reserve floor: **$1.242 (~$1.24)**.
- New cash deployed: **$0.00**.
- Actual cash retained: **$6.21** (100% of liquid balance); no setup was forced.
- Current equity exposure is $328.979817535, approximately 98.15% of account value. SHOP is approximately 39.4% of account value, below but close to the 40% single-name cap. Five-position maximum is already occupied.

## Market regime and event risk

- SPY $769.93 (-0.31%), QQQ $721.47 (-0.29%), IWM $299.575 (-0.66%) at the main quote snapshot. All remained above 20-day and 50-day averages, but all traded below session VWAP during the scan. This is a mixed/fragile risk-on regime, not a clean power-hour risk-on confirmation.
- Sector tape: XLF +0.65%, XLE +0.77%, SMH +0.47%, XLI +0.18%, XLY +0.08%; XLK was -0.07% at 15:37 ET. Energy/financials led while broad tech confirmation was weak.
- Current web context: equities were cautious ahead of Wednesday CPI; U.S.-Iran/Hormuz uncertainty and oil prices were active macro risks. AI infrastructure funding/spending scrutiny was also active. These risks argue against opening unconfirmed overnight exposure.

## Existing holdings — overlay and overnight plan

Overlay dimensions are market regime / sector relative strength / momentum / catalyst-revisions / quality-cash flow / volume-entry confirmation / invalidation clarity / reward-risk, each 0-2.

### AVGO — HOLD, score 11/16 (1/1/1/2/2/0/2/2)

- 0.095750 shares; live $414.22; app average/fill $411.28/$411.278; market value about $39.66. Quote was -1.94% on the day and below VWAP $418.55; day range $413.32-$426.76.
- Daily: SMA20 $393.77, SMA50 $391.46, 20-day return +9.99%, 60-day +1.35%, ATR14 $16.15. SMH's 20/60-day returns were -2.77%/-0.53%, so AVGO retained name-level relative strength despite weak tape.
- Catalyst: Q2 adjusted EPS $2.44 vs $2.32 estimate; company reported record revenue/FCF and AI semiconductor revenue growth, but the market remains sensitive to AI expectations. Next earnings verified 2026-09-02 PM.
- Overnight thesis: AI growth and price above SMA20 preserve the thesis; today's VWAP failure and proximity to the binding stop make it the most fragile semiconductor holding.
- Binding stop/invalidation: **$410.00**; no widening. Resistance/targets: $426.76-$432.73, then **$440**. If $410 breaks, exit rather than average down.
- Data warning: open-tax-lot adjusted cost was $41.71 total (~$435.61/share), while position/fill data reports ~$411.28. Tax-lot basis is used for tax awareness; fill/position average is used for trade management. The cause of the adjustment was not supplied by the broker tools.

### MA — HOLD, score 11/16 (1/2/1/2/2/0/2/1)

- 0.113541 shares; live $562.4801; app average/fill $572.48/$572.4768; value about $63.86. Below VWAP $564.41; day range $561.11-$567.63.
- Daily: SMA20 $554.94, SMA50 $526.45, 20-day -2.15%, 60-day +5.42%, ATR14 $11.18. XLF was a leader (+0.65% day; +5.31% 20-day; +13.29% 60-day).
- Catalyst: Q2 EPS $5.04 vs $4.76; web context reported 12% currency-neutral revenue growth, 18% value-added-services growth, and raised full-year revenue growth outlook.
- Overnight thesis: quality and financial-sector leadership support patience, but MA itself is lagging XLF and lacks volume/VWAP confirmation.
- Binding stop: **$550.00**. Resistance/targets: $567.63, then $583.71. No averaging down.
- Data warning: open-tax-lot adjusted cost was $65.97 total (~$581.02/share), versus the broker position/fill average of ~$572.48. Cause not supplied.

### BAC — HOLD / active profit watch, score 11/16 (1/2/2/2/2/0/2/0)

- 1.046363 shares; live $64.015; average/fill $62.12/$62.1199; value about $66.98. Positive on the day but below VWAP $64.09; day range $63.74-$64.27.
- Daily: SMA20 $61.99, SMA50 $59.39, 20-day +3.54%, 60-day +9.35%, ATR14 $0.96. Trading near the 52-week high ($64.27).
- Catalyst: Q2 EPS $1.21 vs $1.11; BofA reported $31.6B revenue, $9.1B net income and upper-end 6%-8% NII-growth guidance. Next earnings verified 2026-10-14 AM.
- Overnight thesis: financial leadership and strong results remain constructive, but upside to the first target is compressed.
- Binding stop: **$61.40**. Resistance/targets: $64.27 then **$64.80**. Do not add near resistance; take profit if rejection becomes decisive.

### SHOP — HOLD, score 10/16 (1/1/2/2/1/1/2/0)

- 0.862075 shares; live $153.155; average/fill $144.09/$144.0941; value about $132.03. Slightly above VWAP $152.84; day range $151.56-$155.62.
- Daily: SMA20 $127.70, SMA50 $120.49, 20-day +19.84%, 60-day +30.22%, ATR14 $8.97. XLY was only modestly positive.
- Catalyst: Q2 EPS $0.42 vs $0.37. Current web context reports 34% revenue growth, 18% FCF margin and Q3 revenue guidance above prior expectations; valuation remains rich (live fundamental P/E ~112).
- Overnight thesis: strongest portfolio momentum and an intact post-earnings trend, but the account is near its 40% name cap and SHOP is extended; no add.
- Binding stop: **$143.50**. Near resistance $155.62; targets **$160**, then $166. No widening and no add on weakness.

### NESR — HOLD / active profit watch, score 11/16 (1/2/2/2/1/1/2/0)

- 0.736516 shares; live $35.825; fill/average $33.7399/$33.74; value about $26.39. Above VWAP $35.74; day range $35.00-$36.77. Volume was near normal pace and stronger than other holdings.
- Daily: SMA20 $28.14, SMA50 $27.42, 20-day +26.26%, 60-day +37.87%, ATR14 $1.62.
- Catalyst: Q2 EPS $0.44 vs $0.35. Current web context reported record $520.8M revenue (+59.1% YoY), record EBITDA/FCF, and a raised 2026 revenue floor of at least $2B; regional disruption/logistics and capex are risks.
- Overnight thesis: post-earnings momentum and VWAP support remain intact, but the stock reached $36.77 and failed to hold above the $36.60 first target, so this remains an active profit-watch position rather than an add.
- Binding stop: **$31.85**. Tactical support: $35.74 VWAP / $35.00 day low. Resistance/targets: **$36.60-$36.77**, then $38. Exit if it loses VWAP/support decisively; no averaging down.

## Fresh liquid candidates — ranking

1. **RTX — 13/16 (1/2/2/2/2/0/2/2), WATCH, no entry.** Live $223.50; below VWAP $224.36; day $222.34-$225.34; SMA20 $209.93, SMA50 $199.48; 20/60-day +10.21%/+16.47%; ATR14 $5.63. Q2 EPS $1.89 vs $1.66, 16% organic growth, $289B backlog and raised FY guidance. Required trigger **>$225.70 with hold/retest** did not occur. Proposed setup only after confirmation: entry/retest $223-$225.70, invalidation $216, targets $232 then $240.
2. **CRWD — 13/16 (1/2/2/1/1/0/2/2), WATCH, no entry.** Live $222.24; below VWAP $222.75; day $219.24-$225.52; SMA20 $205.91, SMA50 $196.90; 20/60-day +10.39%/+16.73%; ATR14 $9.10. It materially outperformed XLK over 20/60 days, but volume/entry confirmation was absent and earnings are verified for **2026-08-26 PM**. Required entry zone $214-$216 was not revisited/confirmed. Proposed setup: confirmed $214-$216 hold, invalidation $208, targets $232 then $240.
3. **XOM — 11/16 (1/2/1/1/2/0/2/2), WATCH, no entry.** Live $159.965; below VWAP $160.34; day $159.27-$161.67; SMA20 $152.80; 20-day +10.57%; ATR14 $4.29. XLE led intraday and Iran/Hormuz supports oil sensitivity, but XOM failed to hold the day's high/VWAP and Q2 EPS was $3.52 vs $3.76. Preferred $157-$158 retest did not occur. Proposed setup only after a supported retest: entry $157-$158, invalidation ~$153.20, targets $166 then $170. The retrieved XOM daily series produced an anomalous 50-day value and no reliable 60-day return, so that horizon was excluded rather than guessed.

RTX and CRWD exceeded the 13-point serious-candidate threshold but did not meet setup confirmation. With five holdings already open, either would require a confirmed rotation into a materially better setup; no such rotation was justified.

## Orders and fills audit

- Today: no fills and no orders.
- Most recent fill: 2026-08-10 09:53:00 ET, agentic market buy NESR, $24.85 / 0.736516 shares, average $33.7399, order `6a79d7bc-78ff-4efa-87d5-ad2434cf8c2e`, filled.
- Other recent open positions: SHOP bought 2026-08-05 at $144.0941; AVGO bought 2026-08-04 at $411.278; BAC bought 2026-08-03 at $62.1199; MA bought 2026-08-03 at $572.4768. All were filled agentic market orders.
- No review call was made because the final action was no trade. No place/cancel call was made. There was therefore no placement state or fill to verify after this scan.

## Tool/data audit

- No tool call failed.
- XOM's retrieved longer-horizon daily data was internally anomalous; the affected 50/60-day analytics were excluded and flagged.
- The broker exposes no native bracket/stop automation for these fractional cash positions in this workflow; all listed stops are binding management references, not resting broker orders. Independent open-order queries confirmed no protective orders were resting.
